Matches in Wikidata for { <http://www.wikidata.org/entity/Q61867680> ?p ?o ?g. }
- Q61867680 description "2014 nî lūn-bûn" @default.
- Q61867680 description "2014年の論文" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年学术文章" @default.
- Q61867680 description "2014年學術文章" @default.
- Q61867680 description "2014年學術文章" @default.
- Q61867680 description "2014年學術文章" @default.
- Q61867680 description "2014年學術文章" @default.
- Q61867680 description "2014年學術文章" @default.
- Q61867680 description "2014년 논문" @default.
- Q61867680 description "article científic" @default.
- Q61867680 description "article scientific" @default.
- Q61867680 description "article scientifique" @default.
- Q61867680 description "articol științific" @default.
- Q61867680 description "articolo scientifico" @default.
- Q61867680 description "artigo científico" @default.
- Q61867680 description "artigo científico" @default.
- Q61867680 description "artigo científico" @default.
- Q61867680 description "artikel ilmiah" @default.
- Q61867680 description "artikull shkencor" @default.
- Q61867680 description "artikulong pang-agham" @default.
- Q61867680 description "artykuł naukowy" @default.
- Q61867680 description "artículo científico publicado en 2014" @default.
- Q61867680 description "artículu científicu" @default.
- Q61867680 description "bilimsel makale" @default.
- Q61867680 description "bài báo khoa học" @default.
- Q61867680 description "naučni članak" @default.
- Q61867680 description "scienca artikolo" @default.
- Q61867680 description "scientific article published in September 2014" @default.
- Q61867680 description "scientific article published in September 2014" @default.
- Q61867680 description "scientific article published in September 2014" @default.
- Q61867680 description "teaduslik artikkel" @default.
- Q61867680 description "tieteellinen artikkeli" @default.
- Q61867680 description "tudományos cikk" @default.
- Q61867680 description "vedecký článok" @default.
- Q61867680 description "vetenskaplig artikel" @default.
- Q61867680 description "videnskabelig artikel" @default.
- Q61867680 description "vitenskapelig artikkel" @default.
- Q61867680 description "vitskapeleg artikkel" @default.
- Q61867680 description "vědecký článek" @default.
- Q61867680 description "wetenschappelijk artikel" @default.
- Q61867680 description "wissenschaftlicher Artikel" @default.
- Q61867680 description "επιστημονικό άρθρο" @default.
- Q61867680 description "мақолаи илмӣ" @default.
- Q61867680 description "наукова стаття, опублікована у вересні 2014" @default.
- Q61867680 description "научна статия" @default.
- Q61867680 description "научная статья" @default.
- Q61867680 description "научни чланак" @default.
- Q61867680 description "научни чланак" @default.
- Q61867680 description "מאמר מדעי" @default.
- Q61867680 description "مقالة علمية نشرت في سبتمبر 2014" @default.
- Q61867680 description "সেপ্টেম্বর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q61867680 description "บทความทางวิทยาศาสตร์" @default.
- Q61867680 description "სამეცნიერო სტატია" @default.
- Q61867680 name "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 name "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 type Item @default.
- Q61867680 label "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 label "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 prefLabel "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 prefLabel "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 P1433 Q61867680-4161D318-DC60-4645-AFF5-82BEE45F4A43 @default.
- Q61867680 P1476 Q61867680-2945DFF1-4696-46E7-B44C-B5B84CFEEFEA @default.
- Q61867680 P2093 Q61867680-4775208E-3FD8-40B3-99B2-62C52E503268 @default.
- Q61867680 P2093 Q61867680-6484F080-D18F-49A3-ACBA-D3B2193F966F @default.
- Q61867680 P2093 Q61867680-ACC82540-3108-4B52-9AC7-885FFAEA1AE4 @default.
- Q61867680 P2093 Q61867680-BF0D5370-AEAB-4109-AE1B-A04DC4E67366 @default.
- Q61867680 P2093 Q61867680-CF15DE78-9572-4FAC-A4E8-C6CB07987F86 @default.
- Q61867680 P2093 Q61867680-DD12AA69-54DF-491E-A033-2BE8829B2735 @default.
- Q61867680 P2093 Q61867680-DE7E377C-3534-4961-A6F6-11B9A46DF9F0 @default.
- Q61867680 P2093 Q61867680-EF99D887-6F58-468B-A40C-A674C95F279C @default.
- Q61867680 P2093 Q61867680-F1A91EDC-52CF-4980-9280-C13940DA8308 @default.
- Q61867680 P304 Q61867680-7FC4D3A1-4CF6-47A4-A872-71C515F696E5 @default.
- Q61867680 P31 Q61867680-63AE2369-96F7-413B-B358-B9E56CB8C24C @default.
- Q61867680 P356 Q61867680-68740885-8515-460C-ADDE-FC54DAEEB065 @default.
- Q61867680 P433 Q61867680-7C0F534C-1A88-4365-BC0F-A22F3936D708 @default.
- Q61867680 P478 Q61867680-B7831199-4BF2-49C0-86A6-999C1CF9575F @default.
- Q61867680 P577 Q61867680-AD04DC7F-7BB5-4470-B3AA-D6995760993F @default.
- Q61867680 P921 Q61867680-0B27C0EE-8489-4FFF-B36C-9990F0B8BF6C @default.
- Q61867680 P921 Q61867680-1736586E-6E02-4B35-B189-9E007DBBBAE8 @default.
- Q61867680 P921 Q61867680-18B6641B-2995-40B2-B861-7562058E34A3 @default.
- Q61867680 P921 Q61867680-C60EA94D-3F04-42C6-9CA2-82E76CC27E9B @default.
- Q61867680 P921 Q61867680-F76AEA1D-218E-4875-B5F0-BDBD8591B55D @default.
- Q61867680 P356 MDU334.126 @default.
- Q61867680 P1433 Q326122 @default.
- Q61867680 P1476 "741TiPRILOMET-1: AN INTERNATIONAL PHASE 3 MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RILOTUMUMAB PLUS EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED MET-POSITIVE GASTRIC OR GASTROESOP" @default.
- Q61867680 P2093 "A.M. Murad" @default.
- Q61867680 P2093 "D. Cunningham" @default.
- Q61867680 P2093 "D. Ilson" @default.
- Q61867680 P2093 "I. Davidenko" @default.
- Q61867680 P2093 "N. Baker" @default.
- Q61867680 P2093 "N.C. Tebbutt" @default.
- Q61867680 P2093 "R. Jain" @default.
- Q61867680 P2093 "S. Al-Batran" @default.
- Q61867680 P2093 "T. Hoang" @default.
- Q61867680 P304 "iv250-iv250" @default.